Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Neha J. Pagidipati, Keith Marsolo et al.|Journal of the American College of Cardiology|2024Cited by 31
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Neha J. Pagidipati, Elizabeth Lydon et al.|JAMA Network Open|2024Cited by 27
Post-acute dyslipidemia and abnormal BMI in children and adolescents with COVID-19: An EHR Cohort Study from the RECOVER InitiativeYuqing Lei, Yong Chen, Ting Zhou et al.|medRxiv|2025Cited by 1